XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common stock and paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Balance, beginning of period at Dec. 31, 2019   $ 458,316 $ (185,181) $ (923)
Issuance of common stock from exercise of equity awards   4,708    
Payment of withholding taxes related to net share settlement of equity awards   (52,042)    
Equity component of convertible notes issued, net of tax   116,300    
Cost of convertible notes hedge related to the convertible notes issued, net of tax   (117,108)    
Sale of warrants related to the convertible notes issued   96,351    
Equity component of partial settlement of convertible notes   0    
Cost of reacquired equity component on partial settlement of convertible notes   0    
Stock-based compensation expense   34,214    
Net income $ 61,004   61,004  
Repurchase of common stock     0  
Foreign currency translation adjustments 567     567
Change in net unrealized loss on marketable securities, net of tax 0     0
Balance, end of period at Sep. 30, 2020 416,206 540,739 (124,177) (356)
Balance, beginning of period at Jun. 30, 2020   534,868 (163,539) (1,153)
Issuance of common stock from exercise of equity awards   541    
Payment of withholding taxes related to net share settlement of equity awards   (9,069)    
Equity component of convertible notes issued, net of tax   0    
Cost of convertible notes hedge related to the convertible notes issued, net of tax   0    
Sale of warrants related to the convertible notes issued   0    
Equity component of partial settlement of convertible notes   0    
Cost of reacquired equity component on partial settlement of convertible notes   0    
Stock-based compensation expense   14,399    
Net income 39,362   39,362  
Repurchase of common stock     0  
Foreign currency translation adjustments 797     797
Change in net unrealized loss on marketable securities, net of tax 0     0
Balance, end of period at Sep. 30, 2020 416,206 540,739 (124,177) (356)
Balance, beginning of period at Dec. 31, 2020 483,993 534,745 (51,186) 434
Issuance of common stock from exercise of equity awards   3,684    
Payment of withholding taxes related to net share settlement of equity awards   (20,311)    
Equity component of convertible notes issued, net of tax   207,970    
Cost of convertible notes hedge related to the convertible notes issued, net of tax   (213,322)    
Sale of warrants related to the convertible notes issued   220,800    
Equity component of partial settlement of convertible notes   (966,557)    
Cost of reacquired equity component on partial settlement of convertible notes   962,176    
Stock-based compensation expense   77,110    
Net income 92,858   92,858  
Repurchase of common stock     (200,000)  
Foreign currency translation adjustments (302)     (302)
Change in net unrealized loss on marketable securities, net of tax (284)     (284)
Balance, end of period at Sep. 30, 2021 647,815 806,295 (158,328) (152)
Balance, beginning of period at Jun. 30, 2021   762,612 (180,137) 1,924
Issuance of common stock from exercise of equity awards   42    
Payment of withholding taxes related to net share settlement of equity awards   (3,313)    
Equity component of convertible notes issued, net of tax   0    
Cost of convertible notes hedge related to the convertible notes issued, net of tax   0    
Sale of warrants related to the convertible notes issued   0    
Equity component of partial settlement of convertible notes   0    
Cost of reacquired equity component on partial settlement of convertible notes   0    
Stock-based compensation expense   46,954    
Net income 21,809   21,809  
Repurchase of common stock     0  
Foreign currency translation adjustments (1,792)     (1,792)
Change in net unrealized loss on marketable securities, net of tax (284)     (284)
Balance, end of period at Sep. 30, 2021 $ 647,815 $ 806,295 $ (158,328) $ (152)